Align Technology Prepays Goldman Sachs $270 Million To Buy Back Its Own Stock
The accelerated repurchase fulfills a commitment from July and is expected to bring Align's 2026 buybacks to about $500 million.
Align Technology, which makes Invisalign clear aligners, agreed to pay Goldman Sachs $270 million upfront to buy back its own stock, according to an 8-K covering Thursday's agreement. The accelerated repurchase fulfills a pledge the company made in July, CFO John Morici said.
How the repurchase works
Align will receive an initial delivery of about 1.44 million shares in exchange for the prepayment. The final count depends on the volume-weighted average price of Align stock over the life of the agreement, less a discount.
Final settlement is expected no later than about December 29, 2026, though completion may come earlier in certain circumstances. At settlement, Goldman Sachs may owe Align additional shares, or Align may have to deliver shares or pay cash to the bank, the filing says.
The cash comes from the company's own balance sheet. Align had about $1.145 billion in cash and cash equivalents as of September 30, 2026.
Roughly $500 million for the year
"This $270 million accelerated stock repurchase fulfills the share repurchase commitment we announced in July and is expected to bring our total 2026 share repurchases to approximately $500 million," Morici said. He added that the deal "reflects the confidence of our Board and management in Align's long-term value."
The buyback draws on the $1.0 billion repurchase program the board approved in April 2025. The filing puts the program's remaining capacity at $600 million as of Thursday, and the company expects about $330 million to remain available for future repurchases after this deal.
The business behind the buyback
Align designs, makes and sells Invisalign clear aligners, Vivera retainers, iTero intraoral scanners and exocad software for dental laboratories and practitioners. Clear Aligner accounted for about 80% of worldwide net revenues in 2025, with imaging systems and CAD/CAM services making up the other 20%, according to its annual report.
The company says it has helped treat approximately 24.2 million patients with Invisalign and serves approximately 307 thousand doctor customers.
Align expects the agreement to settle by about December 29, 2026, when the final share count and any extra delivery of shares or cash are set.
Sources
- 8-K Filing — ALIGN TECHNOLOGY INC (ALGN) — SEC EDGAR
- Exhibit exhibit991algn_asrxpressre.htm — ALIGN TECHNOLOGY INC 8-K exhibit — SEC EDGAR